The utility of EEG in dementia: a clinical perspective

被引:31
作者
Adamis, D
Sahu, S
Treloar, A
机构
[1] Mem Hosp, Oxleas NHS Trust, London SE18 3RZ, England
[2] Guys & St Thomas NHS Fdn Trust, Dept Ageing & Hlth, London, England
[3] Inst Psychiat, London, England
关键词
electroencephalography; dementia; psychiatric services; review;
D O I
10.1002/gps.1393
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background: Despite being simple and cheap, the EEG is not often used in clinical practice. Methodology: Literature search using PUBMED and Medline. Results: Quantitative EEG can help to identify mild dementia and mild cognitive impairment and can increase diagnostic accuracy when used with other imaging techniques. EEG helps differentiate organic from functional brain disease and predict response to cholinesterase inhibitors and is central in the diagnosis of Creutzfeldt Jacob disease. The accuracy of EEG may be greater than that of CT or MRI scans alone. Discussion: Quantitative EEG may save on specialist interpretation time and enable more routine use of EEG in diagnosis and care. More widespread use of EEG's is indicated. Agreement on the parameters that are best measured on qEEG is still awaited. Copyright (c) 2005 John Wiley & Sons, Ltd.
引用
收藏
页码:1038 / 1045
页数:8
相关论文
共 98 条
[1]  
Adler G, 2004, J NEUROL NEUROSUR PS, V75, P292
[2]   EEG coherence in Alzheimer's dementia [J].
Adler, G ;
Brassen, S ;
Jajcevic, A .
JOURNAL OF NEURAL TRANSMISSION, 2003, 110 (09) :1051-1058
[3]   Short-term rivastigmine treatment reduces EEG slow-wave power in Alzheimer patients [J].
Adler, G ;
Brassen, S .
NEUROPSYCHOBIOLOGY, 2001, 43 (04) :273-276
[4]   EFFECT OF CHOLINERGIC AND ANTICHOLINERGIC DRUGS ON SHORT-TERM-MEMORY IN ALZHEIMERS DEMENTIA - A NEUROPSYCHOLOGICAL AND COMPUTERIZED ELECTROENCEPHALOGRAPHIC STUDY [J].
AGNOLI, A ;
MARTUCCI, N ;
MANNA, V ;
CONTI, L ;
FIORAVANTI, M .
CLINICAL NEUROPHARMACOLOGY, 1983, 6 (04) :311-323
[5]   Disappearance of periodic sharp wave complexes in Creutzfeldt-Jakob disease [J].
Aguglia, U ;
Gambardella, A ;
LePiane, E ;
Messina, D ;
Farnarier, G ;
Oliveri, RL ;
Zappia, M ;
Quattrone, A .
NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY, 1997, 27 (04) :277-282
[6]  
ALHAINEN K, 1993, ACTA NEUROL SCAND, V88, P16
[7]   DISCRIMINATION OF TETRAHYDROAMINOACRIDINE RESPONDERS BY A SINGLE DOSE PHARMACO-EEG IN PATIENTS WITH ALZHEIMERS-DISEASE [J].
ALHAINEN, K ;
PARTANEN, J ;
REINIKAINEN, K ;
LAULUMAA, V ;
SOININEN, H ;
AIRAKSINEN, M ;
RIEKKINEN, P .
NEUROSCIENCE LETTERS, 1991, 127 (01) :113-116
[8]   Responder characteristics to a single oral dose of cholinesterase inhibitor:: A double-blind placebo-controlled study with tacrine in Alzheimer patients [J].
Almkvist, O ;
Jelic, V ;
Amberla, K ;
Hellström-Lindahl, E ;
Meurling, L ;
Nordberg, A .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2001, 12 (01) :22-32
[9]   Alpha EEG activity and subcortical pathology in HIV infection [J].
Baldeweg, T ;
Gruzelier, JH .
INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY, 1997, 26 (1-3) :431-442
[10]  
Balkan S, 2003, ACTA NEUROL BELG, V103, P164